Apixaban Price Trend and Forecast
North America
In the third quarter of 2022,
market growth was constrained, according to Apixaban price patterns. Due to a
decrease in the supply of the API among manufacturers, Apixaban prices
increased significantly in the North American market during the first half of
Q3. The weak Apixaban market has been sustained by the meager downstream
pharmaceutical demand. The US Federal Reserve's tight monetary policy and
high-interest rates implemented around the end of the third quarter severely
harmed the prospects for domestic commerce. Fears of a recession among traders
have made the economic growth barriers stronger. The price of feedstock
titanium dioxide among the dealers has also been negatively impacted by the
declining price of crude oil. In the final phase of Q3 2022, the value accessed
at USD 3250890/MT with an average quarterly declination of 1.43%.
Asia
In the Asia-Pacific region, the
market for Apixaban has seen constricted market fundamentals. Apixaban's
pricing dynamics have been significantly impacted by declining demand, rising
inflation, and large supply, which has kept its market value low in the
regional market. On the upstream price front, the declining Price of
Titanium Dioxide has also caused a further decrease in the cost of
producing Apixaban. The market feelings around Apixaban, however, were
neutralized, and the traders' market value was supported near the end of the
quarter by the muted demand from the downstream pharmaceuticals sector. The
value accessed at the end of Q3 2022 was USD 2650450/MT, with an average
quarterly decline of 3.27%.
Europe
During the third quarter of 2022,
price trends of Apixaban gained a downward momentum in the European region. The
supply turmoil unleashed by Russia's invasion of Ukraine has severely impacted
trade activities across the globe. The upstream input material costs have also
been reported on the lower end, prompting declining market sentiments for
Apixaban. In addition, the ease in material tariffs and stabilizing fuel and
transportation charges have also influenced the operating cost. At the
termination of Q3 2022, the value accessed at USD 2924500/MT with an average
quarterly declination of 0.65%. Thus, the depreciating costs have been passed
on to the terminal consumer at improved prices throughout the third quarter.
ChemAnalyst addresses the key
problematic areas and risks associated with chemical and petrochemical business
globally and enables the decision-maker to make smart choices. It identifies
and analyses factors such as geopolitical risks, environmental risks, raw
material availability, supply chain functionality, disruption in technology and
so on. It targets market volatility and ensures clients navigate through
challenges and pitfalls in an efficient and agile manner. Timeliness and
accuracy of data has been the core competency of ChemAnalyst, benefitting
domestic as well as global industry in tuning in to the real-time data points
to execute multi-billion-dollar projects globally.
Comments
Post a Comment